Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001104659-25-024463
Filing Date
2025-03-17
Accepted
2025-03-17 16:37:58
Documents
6
Effectiveness Date
2025-03-17

Document Format Files

Seq Description Document Type Size
1 FORM S-8 tm258942d1_s8.htm S-8 39139
2 EXHIBIT 5.1 tm258942d1_ex5-1.htm EX-5.1 11629
3 EXHIBIT 23.1 tm258942d1_ex23-1.htm EX-23.1 2062
4 EX-FILING FEES tm258942d1_exfilingfees.htm EX-FILING FEES 10164
5 GRAPHIC tm258942d1_ex5-1img001.jpg GRAPHIC 3395
6 GRAPHIC tm258942d1_ex5-1img002.jpg GRAPHIC 1778
  Complete submission text file 0001104659-25-024463.txt   71578
Mailing Address 259 LIBERTY AVENUE STATEN ISLAND NY 10305
Business Address 259 LIBERTY AVENUE STATEN ISLAND NY 10305 917-533-1469
Acurx Pharmaceuticals, Inc. (Filer) CIK: 0001736243 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-285865 | Film No.: 25745118
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)